A detailed history of Chicago Capital, LLC transactions in Natera, Inc. stock. As of the latest transaction made, Chicago Capital, LLC holds 15,071 shares of NTRA stock, worth $3.08 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
15,071
Previous 2,266 565.09%
Holding current value
$3.08 Million
Previous $364,000 745.6%
% of portfolio
0.07%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 26, 2026

BUY
$160.21 - $209.5 $2.05 Million - $2.68 Million
12,805 Added 565.09%
15,071 $3.08 Million
Q3 2025

Oct 22, 2025

BUY
$133.66 - $181.11 $302,873 - $410,395
2,266 New
2,266 $364,000

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $19.8B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Chicago Capital, LLC Portfolio

Follow Chicago Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chicago Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chicago Capital, LLC with notifications on news.